CHA Biotech Co. Ltd (085660) — Capital Reinvestment Ratio
CHA Biotech Co. Ltd (085660) has a Capital Reinvestment Ratio of 2.52x as of June 2024, meaning it reinvests 3% of its operating cash flow (₩13.77 Billion) in capital expenditures (₩34.71 Billion). Check CHA Biotech Co. Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CHA Biotech Co. Ltd Capital Reinvestment Ratio (2009–2023)
This chart tracks CHA Biotech Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 085660 cash flow conversion.
Annual Capital Reinvestment Ratio for CHA Biotech Co. Ltd (2009–2023)
Year-by-year Capital Reinvestment Ratio for CHA Biotech Co. Ltd from 2009 to 2023. See cash generation quality of CHA Biotech Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 6.46x | ₩11.51 Billion | ₩74.38 Billion | ▲ +24.4% |
| 2021 | 5.19x | ₩22.23 Billion | ₩115.46 Billion | ▲ +93.4% |
| 2020 | 2.69x | ₩47.00 Billion | ₩126.23 Billion | ▼ -37.1% |
| 2019 | 4.27x | ₩25.24 Billion | ₩107.77 Billion | ▲ +311.9% |
| 2018 | 1.04x | ₩75.38 Billion | ₩78.14 Billion | ▼ -66.3% |
| 2017 | 3.07x | ₩12.01 Billion | ₩36.91 Billion | ▲ +1.7% |
| 2016 | 3.02x | ₩11.29 Billion | ₩34.13 Billion | ▲ +496.2% |
| 2015 | 0.51x | ₩61.86 Billion | ₩31.36 Billion | ▲ +20.8% |
| 2013 | 0.42x | ₩66.35 Billion | ₩27.85 Billion | ▼ -37.7% |
| 2012 | 0.67x | ₩45.77 Billion | ₩30.84 Billion | ▼ -8.2% |
| 2011 | 0.73x | ₩34.69 Billion | ₩25.48 Billion | ▲ +22.5% |
| 2010 | 0.60x | ₩42.07 Billion | ₩25.22 Billion | ▼ -19.7% |
| 2009 | 0.75x | ₩24.02 Billion | ₩17.93 Billion | — |